673 filings
Page 9 of 34
8-K
o1l70k8cl5pum11od9a
6 Nov 18
ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance
8:35am
CORRESP
31aauvb0 ov
31 Oct 18
Correspondence with SEC
12:00am
8-K
4owidu
30 Oct 18
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2018 Financial Results
8:35am
UPLOAD
gz9w35 ag0bl82
18 Oct 18
Letter from SEC
12:00am
CORRESP
l49om9wkgt6v6dp
18 Sep 18
Correspondence with SEC
12:00am
UPLOAD
rqond
11 Sep 18
Letter from SEC
12:00am
8-K
kp2hyi0yqk7wr
7 Aug 18
Regulation FD Disclosure
4:36pm
8-K
bo1acq0udn w80kr7
7 Aug 18
ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
8:35am
8-K
pjd5ss0k
1 Aug 18
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2018 Financial Results
8:35am
8-K
t6w6q7ut2do 5h4n
22 May 18
Submission of Matters to a Vote of Security Holders
8:30am
8-K
i2jf lgyddjor
16 May 18
Regulation FD Disclosure
8:30am
8-K
lfxg43ka2rf6 8o3m0
8 May 18
ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance
8:35am
8-K
q3etaa gtklll
1 May 18
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2018 Financial Results
8:35am
CT ORDER
verm4h0a x2dvag
5 Apr 18
Confidential treatment order
12:00am
8-K
921xkedvtmly
7 Mar 18
Regulation FD Disclosure
12:00am
8-K
h39b2c
27 Feb 18
ANI Pharmaceuticals Reports Record Full Year Results, Reports Fourth Quarter 2017 Results, and Provides 2018 Guidance
12:00am